Bridgewater Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-5,730
| Closed | -$293K | – | 814 |
|
2024
Q4 | $293K | Sell |
5,730
-2,478
| -30% | -$127K | ﹤0.01% | 631 |
|
2024
Q3 | $338K | Sell |
8,208
-1,205
| -13% | -$49.7K | ﹤0.01% | 726 |
|
2024
Q2 | $453K | Sell |
9,413
-39,537
| -81% | -$1.9M | ﹤0.01% | 759 |
|
2024
Q1 | $2.35M | Sell |
48,950
-6,960
| -12% | -$334K | 0.01% | 475 |
|
2023
Q4 | $3.63M | Sell |
55,910
-5,109
| -8% | -$332K | 0.02% | 420 |
|
2023
Q3 | $3.99M | Buy |
61,019
+8,530
| +16% | +$558K | 0.02% | 391 |
|
2023
Q2 | $3.05M | Buy |
52,489
+370
| +0.7% | +$21.5K | 0.02% | 400 |
|
2023
Q1 | $3.22M | Buy |
52,119
+893
| +2% | +$55.1K | 0.02% | 380 |
|
2022
Q4 | $3.26M | Sell |
51,226
-16,732
| -25% | -$1.06M | 0.02% | 446 |
|
2022
Q3 | $4.94M | Buy |
67,958
+819
| +1% | +$59.5K | 0.03% | 381 |
|
2022
Q2 | $4.57M | Buy |
67,139
+11,974
| +22% | +$814K | 0.02% | 508 |
|
2022
Q1 | $5M | Buy |
55,165
+18,304
| +50% | +$1.66M | 0.02% | 476 |
|
2021
Q4 | $3.36M | Sell |
36,861
-9,400
| -20% | -$858K | 0.02% | 382 |
|
2021
Q3 | $3.75M | Sell |
46,261
-3,688
| -7% | -$299K | 0.02% | 335 |
|
2021
Q2 | $4.66M | Buy |
+49,949
| New | +$4.66M | 0.03% | 343 |
|